

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | plasma membrane repair (GO:0001778) | 4.58857573 |
| 2 | regulation of relaxation of muscle (GO:1901077) | 4.58581262 |
| 3 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.36346393 |
| 4 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.33666653 |
| 5 | sarcomere organization (GO:0045214) | 4.30498036 |
| 6 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.27216110 |
| 7 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.26311808 |
| 8 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.25709110 |
| 9 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.18771776 |
| 10 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.14508526 |
| 11 | synaptic vesicle maturation (GO:0016188) | 3.99112876 |
| 12 | Golgi transport vesicle coating (GO:0048200) | 3.91894212 |
| 13 | COPI coating of Golgi vesicle (GO:0048205) | 3.91894212 |
| 14 | cardiac myofibril assembly (GO:0055003) | 3.91484567 |
| 15 | protein localization to endosome (GO:0036010) | 3.85303429 |
| 16 | regulation of cell communication by electrical coupling (GO:0010649) | 3.83983363 |
| 17 | cell communication by electrical coupling (GO:0010644) | 3.81488319 |
| 18 | tricarboxylic acid cycle (GO:0006099) | 3.81121495 |
| 19 | cardiac muscle contraction (GO:0060048) | 3.75795937 |
| 20 | protein retention in ER lumen (GO:0006621) | 3.72987132 |
| 21 | cell communication involved in cardiac conduction (GO:0086065) | 3.57685906 |
| 22 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.57554750 |
| 23 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.55854235 |
| 24 | negative regulation of cell killing (GO:0031342) | 3.55854235 |
| 25 | regulation of synapse structural plasticity (GO:0051823) | 3.55648450 |
| 26 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.52588275 |
| 27 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.48227976 |
| 28 | oxygen transport (GO:0015671) | 3.47749786 |
| 29 | activation of protein kinase A activity (GO:0034199) | 3.43585090 |
| 30 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.38503862 |
| 31 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.30165751 |
| 32 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.28995078 |
| 33 | NADH metabolic process (GO:0006734) | 3.27221260 |
| 34 | myofibril assembly (GO:0030239) | 3.27090672 |
| 35 | regulation of actin filament-based movement (GO:1903115) | 3.25067718 |
| 36 | actin-myosin filament sliding (GO:0033275) | 3.24326414 |
| 37 | muscle filament sliding (GO:0030049) | 3.24326414 |
| 38 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.23723899 |
| 39 | positive regulation of receptor recycling (GO:0001921) | 3.20603195 |
| 40 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.18108410 |
| 41 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.18108410 |
| 42 | synaptic vesicle exocytosis (GO:0016079) | 3.16809958 |
| 43 | regulation of early endosome to late endosome transport (GO:2000641) | 3.14157419 |
| 44 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.12557113 |
| 45 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.10281733 |
| 46 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.10245192 |
| 47 | regulation of membrane repolarization (GO:0060306) | 3.09042784 |
| 48 | stress fiber assembly (GO:0043149) | 3.08989758 |
| 49 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.04508189 |
| 50 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.04275591 |
| 51 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.04275591 |
| 52 | barbed-end actin filament capping (GO:0051016) | 3.01429737 |
| 53 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.99807603 |
| 54 | regulation of striated muscle contraction (GO:0006942) | 2.98843335 |
| 55 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.98783483 |
| 56 | protein maturation by protein folding (GO:0022417) | 2.98236489 |
| 57 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.97418258 |
| 58 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.96820467 |
| 59 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.96336760 |
| 60 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.95914611 |
| 61 | oxaloacetate metabolic process (GO:0006107) | 2.95778467 |
| 62 | potassium ion export (GO:0071435) | 2.95426859 |
| 63 | galactose catabolic process (GO:0019388) | 2.93047525 |
| 64 | negative regulation of microtubule polymerization (GO:0031115) | 2.90341346 |
| 65 | glutamate secretion (GO:0014047) | 2.89840973 |
| 66 | proline transport (GO:0015824) | 2.89129966 |
| 67 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.88445149 |
| 68 | regulation of synaptic vesicle transport (GO:1902803) | 2.88344041 |
| 69 | negative regulation of cell size (GO:0045792) | 2.86337277 |
| 70 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.85905325 |
| 71 | positive regulation by symbiont of host defense response (GO:0052509) | 2.82416141 |
| 72 | modulation by symbiont of host defense response (GO:0052031) | 2.82416141 |
| 73 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.82416141 |
| 74 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.82416141 |
| 75 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.82416141 |
| 76 | modulation by symbiont of host immune response (GO:0052553) | 2.82416141 |
| 77 | regulation of ARF protein signal transduction (GO:0032012) | 2.82290866 |
| 78 | regulation of extracellular matrix disassembly (GO:0010715) | 2.80575935 |
| 79 | regulation of cardiac muscle contraction (GO:0055117) | 2.80066585 |
| 80 | regulation of coenzyme metabolic process (GO:0051196) | 2.78893313 |
| 81 | regulation of cofactor metabolic process (GO:0051193) | 2.78893313 |
| 82 | regulation of cation channel activity (GO:2001257) | 2.78783362 |
| 83 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.78642262 |
| 84 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.77355276 |
| 85 | striated muscle contraction (GO:0006941) | 2.74831863 |
| 86 | positive regulation of protein dephosphorylation (GO:0035307) | 2.74078989 |
| 87 | membrane depolarization during action potential (GO:0086010) | 2.73944474 |
| 88 | detection of temperature stimulus (GO:0016048) | 2.70189767 |
| 89 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.69826528 |
| 90 | sodium ion export (GO:0071436) | 2.69516732 |
| 91 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.69312573 |
| 92 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.68592943 |
| 93 | regulation of the force of heart contraction (GO:0002026) | 2.68406362 |
| 94 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.67967906 |
| 95 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.66991024 |
| 96 | positive regulation of cation channel activity (GO:2001259) | 2.65865851 |
| 97 | actomyosin structure organization (GO:0031032) | 2.64955607 |
| 98 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.64668843 |
| 99 | cortical actin cytoskeleton organization (GO:0030866) | 2.62021542 |
| 100 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.61832079 |
| 101 | detection of molecule of bacterial origin (GO:0032490) | 2.61773582 |
| 102 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.61755984 |
| 103 | carnitine shuttle (GO:0006853) | 2.60321375 |
| 104 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.59388007 |
| 105 | glucose 6-phosphate metabolic process (GO:0051156) | 2.58617622 |
| 106 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.56331144 |
| 107 | protein targeting to plasma membrane (GO:0072661) | 2.56160071 |
| 108 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.55258578 |
| 109 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.53159482 |
| 110 | macrophage activation involved in immune response (GO:0002281) | 2.51752140 |
| 111 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.51666866 |
| 112 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.51666866 |
| 113 | actin filament depolymerization (GO:0030042) | 2.50942458 |
| 114 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.50598945 |
| 115 | detection of other organism (GO:0098543) | 2.50412365 |
| 116 | vocalization behavior (GO:0071625) | 2.50125331 |
| 117 | basement membrane organization (GO:0071711) | 2.48882520 |
| 118 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.48864915 |
| 119 | negative regulation of cation channel activity (GO:2001258) | 2.47809472 |
| 120 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.47525289 |
| 121 | adenosine receptor signaling pathway (GO:0001973) | 2.47314045 |
| 122 | cellular potassium ion homeostasis (GO:0030007) | 2.46785291 |
| 123 | peripheral nervous system neuron development (GO:0048935) | 2.46391490 |
| 124 | modulation by symbiont of host cellular process (GO:0044068) | 2.46265088 |
| 125 | response to peptidoglycan (GO:0032494) | 2.45997858 |
| 126 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.45737454 |
| 127 | regulation of ARF GTPase activity (GO:0032312) | 2.45722160 |
| 128 | negative regulation of potassium ion transport (GO:0043267) | 2.44465919 |
| 129 | signal complex assembly (GO:0007172) | 2.44405758 |
| 130 | positive regulation of axon extension (GO:0045773) | 2.44375303 |
| 131 | regulation of defense response to virus by virus (GO:0050690) | 2.44302047 |
| 132 | detection of external biotic stimulus (GO:0098581) | 2.43935613 |
| 133 | detection of bacterium (GO:0016045) | 2.43826450 |
| 134 | skin morphogenesis (GO:0043589) | 2.43621235 |
| 135 | oxidative phosphorylation (GO:0006119) | 2.43539355 |
| 136 | locomotory exploration behavior (GO:0035641) | 2.42270795 |
| 137 | succinate metabolic process (GO:0006105) | 2.39747361 |
| 138 | actin-mediated cell contraction (GO:0070252) | 2.39227745 |
| 139 | pinocytosis (GO:0006907) | 2.39151490 |
| 140 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.38941745 |
| 141 | regulation of heart rate (GO:0002027) | 2.38757760 |
| 142 | regulation of heart contraction (GO:0008016) | 2.38705051 |
| 143 | neuronal action potential propagation (GO:0019227) | 2.38644579 |
| 144 | heart contraction (GO:0060047) | 2.38353233 |
| 145 | heart process (GO:0003015) | 2.38353233 |
| 146 | mannose metabolic process (GO:0006013) | 2.37529491 |
| 147 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.35867720 |
| 148 | negative regulation of ion transmembrane transporter activity (GO:0032413) | 2.35788795 |
| 149 | positive regulation of sodium ion transport (GO:0010765) | 2.35337020 |
| 150 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.33460531 |
| 151 | regulation of protein dephosphorylation (GO:0035304) | 2.33344276 |
| 152 | fibril organization (GO:0097435) | 2.32985008 |
| 153 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.32319918 |
| 154 | response to laminar fluid shear stress (GO:0034616) | 2.31439459 |
| 155 | adherens junction assembly (GO:0034333) | 2.30174980 |
| 156 | negative regulation of necroptotic process (GO:0060546) | 2.28165815 |
| 157 | cortical cytoskeleton organization (GO:0030865) | 2.28052686 |
| 158 | germinal center formation (GO:0002467) | 2.27911154 |
| 159 | pentose-phosphate shunt (GO:0006098) | 2.27000230 |
| 160 | cell-cell junction maintenance (GO:0045217) | 2.25081027 |
| 161 | modulation by virus of host process (GO:0019054) | 2.24406254 |
| 162 | endothelial cell chemotaxis (GO:0035767) | 2.24353664 |
| 163 | semaphorin-plexin signaling pathway (GO:0071526) | 2.24256497 |
| 164 | regulation of necrotic cell death (GO:0010939) | 2.23880357 |
| 165 | focal adhesion assembly (GO:0048041) | 2.23331461 |
| 166 | cell-substrate adherens junction assembly (GO:0007045) | 2.23331461 |
| 167 | extracellular fibril organization (GO:0043206) | 2.21813898 |
| 168 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.21633023 |
| 169 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.20189172 |
| 170 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.17998699 |
| 171 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.17495667 |
| 172 | activation of Rac GTPase activity (GO:0032863) | 2.16182896 |
| 173 | amyloid precursor protein catabolic process (GO:0042987) | 2.14311434 |
| 174 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.14029013 |
| 175 | regulation of necroptotic process (GO:0060544) | 2.11881451 |
| 176 | apoptotic process involved in morphogenesis (GO:0060561) | 2.11779980 |
| 177 | regulation of leukocyte degranulation (GO:0043300) | 2.11551711 |
| 178 | glycolytic process (GO:0006096) | 2.10601487 |
| 179 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.10453445 |
| 180 | layer formation in cerebral cortex (GO:0021819) | 2.10181871 |
| 181 | regulation of superoxide anion generation (GO:0032928) | 2.10072701 |
| 182 | regulation of regulated secretory pathway (GO:1903305) | 2.08328932 |
| 183 | modulation by virus of host morphology or physiology (GO:0019048) | 2.07837697 |
| 184 | negative regulation of necrotic cell death (GO:0060547) | 2.07658011 |
| 185 | actin filament polymerization (GO:0030041) | 2.06847138 |
| 186 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.06492215 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.95713581 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.33618876 |
| 3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.94412136 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.79300692 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.76485758 |
| 6 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.71768632 |
| 7 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.27067375 |
| 8 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.23908304 |
| 9 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.17924417 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.10209199 |
| 11 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04671328 |
| 12 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91342230 |
| 13 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.89228225 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.86034838 |
| 15 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.81873151 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.77553517 |
| 17 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.72779052 |
| 18 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.72245282 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.68407502 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.68397992 |
| 21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.67564658 |
| 22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.66134956 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.64240475 |
| 24 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.63345731 |
| 25 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.62706257 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.61691169 |
| 27 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.61397348 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.59764470 |
| 29 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.59718605 |
| 30 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.57917141 |
| 31 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.57134813 |
| 32 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.56666737 |
| 33 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.56553437 |
| 34 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.56359371 |
| 35 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.54602405 |
| 36 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.53613238 |
| 37 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.51998294 |
| 38 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.51265685 |
| 39 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.50877226 |
| 40 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.49800939 |
| 41 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.49608444 |
| 42 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.49264732 |
| 43 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.48047757 |
| 44 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.48047757 |
| 45 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.47745981 |
| 46 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.47463629 |
| 47 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.45114379 |
| 48 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.42037904 |
| 49 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.37218768 |
| 50 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.35434581 |
| 51 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34944539 |
| 52 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.34243484 |
| 53 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.33536722 |
| 54 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.33311017 |
| 55 | KDM2B_26808549_Chip-Seq_K562_Human | 1.32992472 |
| 56 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.32458499 |
| 57 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.32174969 |
| 58 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31787273 |
| 59 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.31403570 |
| 60 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.31403570 |
| 61 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.31338555 |
| 62 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.30926700 |
| 63 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.30753169 |
| 64 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.29355818 |
| 65 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29353411 |
| 66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27917933 |
| 67 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.27324387 |
| 68 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.27092606 |
| 69 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.26270205 |
| 70 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.25317785 |
| 71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25085423 |
| 72 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.25034116 |
| 73 | MAF_26560356_Chip-Seq_TH2_Human | 1.24831777 |
| 74 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.24661698 |
| 75 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.24269393 |
| 76 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.23905957 |
| 77 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.23310175 |
| 78 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22968856 |
| 79 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.22579887 |
| 80 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.22237849 |
| 81 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.22209482 |
| 82 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22156710 |
| 83 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.21800092 |
| 84 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21728901 |
| 85 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.21398873 |
| 86 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.21067419 |
| 87 | UTX_26944678_Chip-Seq_JUKART_Human | 1.20000378 |
| 88 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.19714594 |
| 89 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18524583 |
| 90 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18129839 |
| 91 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.17695438 |
| 92 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.17581207 |
| 93 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.17436629 |
| 94 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17087969 |
| 95 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16728734 |
| 96 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.15522174 |
| 97 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.15131782 |
| 98 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.15002435 |
| 99 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.14892818 |
| 100 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14788316 |
| 101 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.14679931 |
| 102 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.12635537 |
| 103 | P68_20966046_ChIP-Seq_HELA_Human | 1.12392260 |
| 104 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.10988633 |
| 105 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10937368 |
| 106 | ATF3_27146783_Chip-Seq_COLON_Human | 1.10085954 |
| 107 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09769375 |
| 108 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08830307 |
| 109 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.08121654 |
| 110 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06465457 |
| 111 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.06425026 |
| 112 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.06405897 |
| 113 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.06041153 |
| 114 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05944770 |
| 115 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05796057 |
| 116 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.05625649 |
| 117 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.04975774 |
| 118 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04801536 |
| 119 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.04734450 |
| 120 | MYC_22102868_ChIP-Seq_BL_Human | 1.03971856 |
| 121 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.03931074 |
| 122 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03260692 |
| 123 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.03111169 |
| 124 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.02689640 |
| 125 | MAF_26560356_Chip-Seq_TH1_Human | 1.02265964 |
| 126 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.02216892 |
| 127 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.02094728 |
| 128 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.01566480 |
| 129 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.01299221 |
| 130 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.00849364 |
| 131 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.00708536 |
| 132 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.99481685 |
| 133 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.98597465 |
| 134 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.98549733 |
| 135 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98538898 |
| 136 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.98444670 |
| 137 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98070803 |
| 138 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.98022607 |
| 139 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96240250 |
| 140 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.96182879 |
| 141 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.94799372 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.93033655 |
| 2 | MP0000751_myopathy | 4.10696417 |
| 3 | MP0004084_abnormal_cardiac_muscle | 3.23070250 |
| 4 | MP0003646_muscle_fatigue | 3.15328677 |
| 5 | MP0002735_abnormal_chemical_nociception | 3.12065395 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 2.97161378 |
| 7 | MP0004859_abnormal_synaptic_plasticity | 2.92516251 |
| 8 | MP0001968_abnormal_touch/_nociception | 2.90033859 |
| 9 | MP0000749_muscle_degeneration | 2.89823472 |
| 10 | MP0008260_abnormal_autophagy | 2.87713583 |
| 11 | MP0005451_abnormal_body_composition | 2.78778998 |
| 12 | MP0004215_abnormal_myocardial_fiber | 2.77796783 |
| 13 | MP0004858_abnormal_nervous_system | 2.77389610 |
| 14 | MP0003436_decreased_susceptibility_to | 2.74936976 |
| 15 | MP0002877_abnormal_melanocyte_morpholog | 2.72519439 |
| 16 | MP0009840_abnormal_foam_cell | 2.71359633 |
| 17 | MP0002736_abnormal_nociception_after | 2.57199920 |
| 18 | MP0004036_abnormal_muscle_relaxation | 2.54520592 |
| 19 | MP0004130_abnormal_muscle_cell | 2.36646886 |
| 20 | MP0005330_cardiomyopathy | 2.14579836 |
| 21 | MP0004510_myositis | 2.12788073 |
| 22 | MP0004270_analgesia | 2.06178416 |
| 23 | MP0002733_abnormal_thermal_nociception | 2.03208976 |
| 24 | MP0008775_abnormal_heart_ventricle | 1.99089053 |
| 25 | MP0002972_abnormal_cardiac_muscle | 1.93359168 |
| 26 | MP0000747_muscle_weakness | 1.87078055 |
| 27 | MP0006276_abnormal_autonomic_nervous | 1.85319602 |
| 28 | MP0004087_abnormal_muscle_fiber | 1.83786529 |
| 29 | MP0004484_altered_response_of | 1.77329904 |
| 30 | MP0001970_abnormal_pain_threshold | 1.77099467 |
| 31 | MP0003635_abnormal_synaptic_transmissio | 1.72731932 |
| 32 | MP0000604_amyloidosis | 1.72583670 |
| 33 | MP0002909_abnormal_adrenal_gland | 1.70893154 |
| 34 | MP0002734_abnormal_mechanical_nocicepti | 1.70748542 |
| 35 | MP0000343_altered_response_to | 1.65137673 |
| 36 | MP0005620_abnormal_muscle_contractility | 1.63057259 |
| 37 | MP0003279_aneurysm | 1.59750940 |
| 38 | MP0000858_altered_metastatic_potential | 1.59311875 |
| 39 | MP0002269_muscular_atrophy | 1.57357523 |
| 40 | MP0003091_abnormal_cell_migration | 1.55716287 |
| 41 | MP0005385_cardiovascular_system_phenoty | 1.55191345 |
| 42 | MP0001544_abnormal_cardiovascular_syste | 1.55191345 |
| 43 | MP0004145_abnormal_muscle_electrophysio | 1.53165705 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.52708950 |
| 45 | MP0000759_abnormal_skeletal_muscle | 1.52090868 |
| 46 | MP0003137_abnormal_impulse_conducting | 1.52090133 |
| 47 | MP0004085_abnormal_heartbeat | 1.51845990 |
| 48 | MP0002106_abnormal_muscle_physiology | 1.50470268 |
| 49 | MP0000750_abnormal_muscle_regeneration | 1.49817403 |
| 50 | MP0003690_abnormal_glial_cell | 1.45630960 |
| 51 | MP0001986_abnormal_taste_sensitivity | 1.43938527 |
| 52 | MP0001849_ear_inflammation | 1.41840779 |
| 53 | * MP0002419_abnormal_innate_immunity | 1.41717949 |
| 54 | MP0000920_abnormal_myelination | 1.38555595 |
| 55 | MP0005025_abnormal_response_to | 1.37631567 |
| 56 | MP0003123_paternal_imprinting | 1.36564135 |
| 57 | MP0003828_pulmonary_edema | 1.35344706 |
| 58 | MP0006036_abnormal_mitochondrial_physio | 1.34855384 |
| 59 | MP0000678_abnormal_parathyroid_gland | 1.34561692 |
| 60 | MP0006082_CNS_inflammation | 1.32399463 |
| 61 | MP0001958_emphysema | 1.32237690 |
| 62 | MP0008438_abnormal_cutaneous_collagen | 1.31502665 |
| 63 | MP0005257_abnormal_intraocular_pressure | 1.29579421 |
| 64 | MP0004947_skin_inflammation | 1.27472321 |
| 65 | MP0010630_abnormal_cardiac_muscle | 1.26141460 |
| 66 | MP0005369_muscle_phenotype | 1.21049144 |
| 67 | MP0002998_abnormal_bone_remodeling | 1.18683788 |
| 68 | MP0006138_congestive_heart_failure | 1.17587409 |
| 69 | MP0000013_abnormal_adipose_tissue | 1.17092081 |
| 70 | MP0003221_abnormal_cardiomyocyte_apopto | 1.15610458 |
| 71 | MP0002272_abnormal_nervous_system | 1.15412436 |
| 72 | MP0000003_abnormal_adipose_tissue | 1.14595447 |
| 73 | MP0009745_abnormal_behavioral_response | 1.13868178 |
| 74 | MP0002063_abnormal_learning/memory/cond | 1.12016485 |
| 75 | MP0000685_abnormal_immune_system | 1.11570757 |
| 76 | MP0008569_lethality_at_weaning | 1.11017445 |
| 77 | MP0003880_abnormal_central_pattern | 1.10072218 |
| 78 | MP0004233_abnormal_muscle_weight | 1.09454412 |
| 79 | MP0003329_amyloid_beta_deposits | 1.08412134 |
| 80 | MP0005000_abnormal_immune_tolerance | 1.07952208 |
| 81 | MP0004811_abnormal_neuron_physiology | 1.06803740 |
| 82 | MP0003453_abnormal_keratinocyte_physiol | 1.06318694 |
| 83 | MP0001348_abnormal_lacrimal_gland | 1.06296666 |
| 84 | MP0005375_adipose_tissue_phenotype | 1.06045275 |
| 85 | MP0005409_darkened_coat_color | 1.05262031 |
| 86 | MP0002064_seizures | 1.04929890 |
| 87 | MP0008874_decreased_physiological_sensi | 1.04646021 |
| 88 | MP0001501_abnormal_sleep_pattern | 1.04517347 |
| 89 | MP0008961_abnormal_basal_metabolism | 1.03511151 |
| 90 | MP0003634_abnormal_glial_cell | 1.03247105 |
| 91 | MP0003075_altered_response_to | 1.02341460 |
| 92 | MP0005076_abnormal_cell_differentiation | 1.01071089 |
| 93 | MP0005023_abnormal_wound_healing | 1.00018425 |
| 94 | MP0005666_abnormal_adipose_tissue | 0.99318732 |
| 95 | MP0001790_abnormal_immune_system | 0.98093126 |
| 96 | MP0005387_immune_system_phenotype | 0.98093126 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 0.97838218 |
| 98 | MP0003566_abnormal_cell_adhesion | 0.96480627 |
| 99 | MP0005165_increased_susceptibility_to | 0.95126056 |
| 100 | MP0004185_abnormal_adipocyte_glucose | 0.94439667 |
| 101 | MP0005535_abnormal_body_temperature | 0.92873346 |
| 102 | MP0005390_skeleton_phenotype | 0.91099901 |
| 103 | MP0003879_abnormal_hair_cell | 0.89539900 |
| 104 | MP0001835_abnormal_antigen_presentation | 0.87283683 |
| 105 | MP0001542_abnormal_bone_strength | 0.86534556 |
| 106 | MP0000767_abnormal_smooth_muscle | 0.85814167 |
| 107 | MP0002067_abnormal_sensory_capabilities | 0.85595787 |
| 108 | MP0003045_fibrosis | 0.85318244 |
| 109 | MP0000230_abnormal_systemic_arterial | 0.85047235 |
| 110 | MP0009780_abnormal_chondrocyte_physiolo | 0.85002350 |
| 111 | MP0009046_muscle_twitch | 0.84567666 |
| 112 | MP0003172_abnormal_lysosome_physiology | 0.83899477 |
| 113 | MP0002184_abnormal_innervation | 0.82680789 |
| 114 | MP0005397_hematopoietic_system_phenotyp | 0.82035091 |
| 115 | MP0001545_abnormal_hematopoietic_system | 0.82035091 |
| 116 | MP0002723_abnormal_immune_serum | 0.82032381 |
| 117 | MP0002148_abnormal_hypersensitivity_rea | 0.80299923 |
| 118 | MP0003448_altered_tumor_morphology | 0.79894104 |
| 119 | MP0010368_abnormal_lymphatic_system | 0.79318974 |
| 120 | MP0002896_abnormal_bone_mineralization | 0.79165591 |
| 121 | MP0002572_abnormal_emotion/affect_behav | 0.79028041 |
| 122 | MP0003633_abnormal_nervous_system | 0.78693997 |
| 123 | MP0000733_abnormal_muscle_development | 0.78663456 |
| 124 | MP0009333_abnormal_splenocyte_physiolog | 0.78635740 |
| 125 | MP0010234_abnormal_vibrissa_follicle | 0.77702377 |
| 126 | MP0002089_abnormal_postnatal_growth/wei | 0.77335369 |
| 127 | MP0003303_peritoneal_inflammation | 0.76012535 |
| 128 | MP0005058_abnormal_lysosome_morphology | 0.75287392 |
| 129 | * MP0002420_abnormal_adaptive_immunity | 0.75247346 |
| 130 | * MP0001819_abnormal_immune_cell | 0.74978170 |
| 131 | MP0009278_abnormal_bone_marrow | 0.74856720 |
| 132 | MP0004147_increased_porphyrin_level | 0.72606425 |
| 133 | MP0001853_heart_inflammation | 0.71659355 |
| 134 | MP0002452_abnormal_antigen_presenting | 0.71124855 |
| 135 | MP0010155_abnormal_intestine_physiology | 0.71046490 |
| 136 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.70229843 |
| 137 | MP0004808_abnormal_hematopoietic_stem | 0.70039340 |
| 138 | MP0005083_abnormal_biliary_tract | 0.69971035 |
| 139 | MP0000681_abnormal_thyroid_gland | 0.69328640 |
| 140 | MP0004272_abnormal_basement_membrane | 0.69155141 |
| 141 | MP0002332_abnormal_exercise_endurance | 0.68175293 |
| 142 | MP0005275_abnormal_skin_tensile | 0.68091027 |
| 143 | MP0004924_abnormal_behavior | 0.65950275 |
| 144 | MP0005386_behavior/neurological_phenoty | 0.65950275 |
| 145 | MP0005166_decreased_susceptibility_to | 0.65725143 |
| 146 | MP0003300_gastrointestinal_ulcer | 0.65025232 |
| 147 | MP0005464_abnormal_platelet_physiology | 0.64382257 |
| 148 | MP0006035_abnormal_mitochondrial_morpho | 0.64071520 |
| 149 | MP0005623_abnormal_meninges_morphology | 0.62908854 |
| 150 | MP0003183_abnormal_peptide_metabolism | 0.62619088 |
| 151 | MP0003724_increased_susceptibility_to | 0.62426566 |
| 152 | MP0001440_abnormal_grooming_behavior | 0.61424345 |
| 153 | MP0009785_altered_susceptibility_to | 0.61282623 |
| 154 | MP0003705_abnormal_hypodermis_morpholog | 0.60342259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 4.68558372 |
| 2 | Myotonia (HP:0002486) | 4.05504251 |
| 3 | Asymmetric septal hypertrophy (HP:0001670) | 3.53472629 |
| 4 | Exercise-induced myalgia (HP:0003738) | 3.52878663 |
| 5 | Myokymia (HP:0002411) | 3.48885596 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 3.47405780 |
| 7 | Calf muscle hypertrophy (HP:0008981) | 3.45845114 |
| 8 | Pheochromocytoma (HP:0002666) | 3.44846491 |
| 9 | Ventricular tachycardia (HP:0004756) | 3.42704466 |
| 10 | Atrial fibrillation (HP:0005110) | 3.33744320 |
| 11 | Primary atrial arrhythmia (HP:0001692) | 3.26812865 |
| 12 | Neuroendocrine neoplasm (HP:0100634) | 3.26023141 |
| 13 | Palpitations (HP:0001962) | 3.23882127 |
| 14 | Supraventricular tachycardia (HP:0004755) | 3.21831134 |
| 15 | Supraventricular arrhythmia (HP:0005115) | 3.16883667 |
| 16 | Abnormality of the calf musculature (HP:0001430) | 3.12546510 |
| 17 | Bundle branch block (HP:0011710) | 3.06912549 |
| 18 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.06577758 |
| 19 | Lipoatrophy (HP:0100578) | 3.03883157 |
| 20 | Myoglobinuria (HP:0002913) | 3.02294663 |
| 21 | Abnormal gallbladder physiology (HP:0012438) | 3.00126898 |
| 22 | Cholecystitis (HP:0001082) | 3.00126898 |
| 23 | EMG: myopathic abnormalities (HP:0003458) | 2.99773770 |
| 24 | Hyporeflexia of lower limbs (HP:0002600) | 2.99737639 |
| 25 | Muscle fiber splitting (HP:0003555) | 2.99148668 |
| 26 | Neurofibrillary tangles (HP:0002185) | 2.96271643 |
| 27 | Premature rupture of membranes (HP:0001788) | 2.95444524 |
| 28 | Distal upper limb amyotrophy (HP:0007149) | 2.94910415 |
| 29 | Upper limb amyotrophy (HP:0009129) | 2.94910415 |
| 30 | Visual hallucinations (HP:0002367) | 2.93485602 |
| 31 | Ventricular fibrillation (HP:0001663) | 2.79805671 |
| 32 | Increased variability in muscle fiber diameter (HP:0003557) | 2.77052966 |
| 33 | Amyloidosis (HP:0011034) | 2.73231081 |
| 34 | Hypercortisolism (HP:0001578) | 2.67739692 |
| 35 | Cerebral inclusion bodies (HP:0100314) | 2.65159650 |
| 36 | Increased connective tissue (HP:0009025) | 2.64850751 |
| 37 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.62122347 |
| 38 | Subaortic stenosis (HP:0001682) | 2.62122347 |
| 39 | Ventricular arrhythmia (HP:0004308) | 2.59491058 |
| 40 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.58852949 |
| 41 | Abnormality of pain sensation (HP:0010832) | 2.58107920 |
| 42 | Impaired pain sensation (HP:0007328) | 2.58107920 |
| 43 | Difficulty climbing stairs (HP:0003551) | 2.56405681 |
| 44 | Obstructive sleep apnea (HP:0002870) | 2.54069843 |
| 45 | Syncope (HP:0001279) | 2.52748311 |
| 46 | Limb-girdle muscle atrophy (HP:0003797) | 2.51570774 |
| 47 | Abnormality of macrophages (HP:0004311) | 2.50272038 |
| 48 | Eczematoid dermatitis (HP:0000976) | 2.50134741 |
| 49 | Dysostosis multiplex (HP:0000943) | 2.49443130 |
| 50 | Prolonged QT interval (HP:0001657) | 2.49252964 |
| 51 | Hand muscle atrophy (HP:0009130) | 2.49208499 |
| 52 | Broad metatarsal (HP:0001783) | 2.49014811 |
| 53 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.48412856 |
| 54 | Spinal canal stenosis (HP:0003416) | 2.41105431 |
| 55 | Axonal loss (HP:0003447) | 2.38598829 |
| 56 | Rapidly progressive (HP:0003678) | 2.38439733 |
| 57 | Achilles tendon contracture (HP:0001771) | 2.37140819 |
| 58 | Muscle stiffness (HP:0003552) | 2.36680621 |
| 59 | Abnormality of the vocal cords (HP:0008777) | 2.36345251 |
| 60 | Dilated cardiomyopathy (HP:0001644) | 2.35893634 |
| 61 | Protrusio acetabuli (HP:0003179) | 2.35706388 |
| 62 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.35356526 |
| 63 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.35356526 |
| 64 | Abnormality of glycolipid metabolism (HP:0010969) | 2.35356526 |
| 65 | Right ventricular cardiomyopathy (HP:0011663) | 2.28754634 |
| 66 | Abnormal EKG (HP:0003115) | 2.28239992 |
| 67 | Neuronal loss in central nervous system (HP:0002529) | 2.26376623 |
| 68 | Type 1 muscle fiber predominance (HP:0003803) | 2.24867767 |
| 69 | Heart block (HP:0012722) | 2.20950589 |
| 70 | Systemic lupus erythematosus (HP:0002725) | 2.19678018 |
| 71 | Conjunctival hamartoma (HP:0100780) | 2.18959967 |
| 72 | Interstitial pulmonary disease (HP:0006530) | 2.18395213 |
| 73 | Abnormal atrioventricular conduction (HP:0005150) | 2.17637510 |
| 74 | Difficulty running (HP:0009046) | 2.16236472 |
| 75 | Bradycardia (HP:0001662) | 2.16059292 |
| 76 | Hypoventilation (HP:0002791) | 2.15783196 |
| 77 | Rhabdomyolysis (HP:0003201) | 2.15640105 |
| 78 | Abnormality of the Achilles tendon (HP:0005109) | 2.13438553 |
| 79 | Focal motor seizures (HP:0011153) | 2.13091738 |
| 80 | Myopathic facies (HP:0002058) | 2.12434309 |
| 81 | Nuclear cataract (HP:0100018) | 2.12410447 |
| 82 | Atrioventricular block (HP:0001678) | 2.12292772 |
| 83 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.10659569 |
| 84 | Mucopolysacchariduria (HP:0008155) | 2.10659569 |
| 85 | Cervical subluxation (HP:0003308) | 2.09759759 |
| 86 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.09658008 |
| 87 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.09658008 |
| 88 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.09658008 |
| 89 | Insomnia (HP:0100785) | 2.08705047 |
| 90 | Depression (HP:0000716) | 2.08492352 |
| 91 | Orchitis (HP:0100796) | 2.07287537 |
| 92 | Oligomenorrhea (HP:0000876) | 2.06875886 |
| 93 | Hemorrhage of the eye (HP:0011885) | 2.06446202 |
| 94 | Myositis (HP:0100614) | 2.06341082 |
| 95 | Distal arthrogryposis (HP:0005684) | 2.06332325 |
| 96 | Ragged-red muscle fibers (HP:0003200) | 2.05822449 |
| 97 | Hypothermia (HP:0002045) | 2.03958440 |
| 98 | Neoplasm of head and neck (HP:0012288) | 2.02852335 |
| 99 | Esophageal neoplasm (HP:0100751) | 2.02852335 |
| 100 | Foot dorsiflexor weakness (HP:0009027) | 2.02671251 |
| 101 | Recurrent abscess formation (HP:0002722) | 2.02179740 |
| 102 | Papilledema (HP:0001085) | 2.02105753 |
| 103 | Cellulitis (HP:0100658) | 2.01056565 |
| 104 | Failure to thrive in infancy (HP:0001531) | 1.99808557 |
| 105 | J-shaped sella turcica (HP:0002680) | 1.99240697 |
| 106 | Hepatocellular necrosis (HP:0001404) | 1.98941370 |
| 107 | Focal seizures (HP:0007359) | 1.98559147 |
| 108 | Hepatic necrosis (HP:0002605) | 1.97862442 |
| 109 | Loss of speech (HP:0002371) | 1.97848966 |
| 110 | Areflexia of lower limbs (HP:0002522) | 1.96566481 |
| 111 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.96079980 |
| 112 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.96027551 |
| 113 | Action tremor (HP:0002345) | 1.95956930 |
| 114 | Cerebral hemorrhage (HP:0001342) | 1.95806451 |
| 115 | Striae distensae (HP:0001065) | 1.95141887 |
| 116 | Supranuclear gaze palsy (HP:0000605) | 1.94303422 |
| 117 | Abnormality of the foot musculature (HP:0001436) | 1.94017587 |
| 118 | Neoplasm of the adrenal gland (HP:0100631) | 1.93291461 |
| 119 | Increased muscle lipid content (HP:0009058) | 1.93059272 |
| 120 | Spinal rigidity (HP:0003306) | 1.92705764 |
| 121 | Growth hormone excess (HP:0000845) | 1.91986784 |
| 122 | Ankle clonus (HP:0011448) | 1.91578798 |
| 123 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.91245800 |
| 124 | Dilatation of the ascending aorta (HP:0005111) | 1.89409660 |
| 125 | Peritonitis (HP:0002586) | 1.88606805 |
| 126 | Left ventricular hypertrophy (HP:0001712) | 1.88044041 |
| 127 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.86767515 |
| 128 | Mitral regurgitation (HP:0001653) | 1.86305886 |
| 129 | Distal lower limb muscle weakness (HP:0009053) | 1.85291021 |
| 130 | Purpura (HP:0000979) | 1.83578930 |
| 131 | Abnormality of complement system (HP:0005339) | 1.82221460 |
| 132 | Long toe (HP:0010511) | 1.81685400 |
| 133 | Polycythemia (HP:0001901) | 1.80079724 |
| 134 | Vertebral compression fractures (HP:0002953) | 1.79973385 |
| 135 | Sudden cardiac death (HP:0001645) | 1.79955904 |
| 136 | Deep venous thrombosis (HP:0002625) | 1.79826672 |
| 137 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.79290564 |
| 138 | Facial diplegia (HP:0001349) | 1.78461580 |
| 139 | Aneurysm (HP:0002617) | 1.78391985 |
| 140 | Enlarged penis (HP:0000040) | 1.78260474 |
| 141 | Decreased motor nerve conduction velocity (HP:0003431) | 1.78218258 |
| 142 | Bulbar palsy (HP:0001283) | 1.77670250 |
| 143 | Ulnar claw (HP:0001178) | 1.77342706 |
| 144 | Hypertriglyceridemia (HP:0002155) | 1.75976646 |
| 145 | Lower limb amyotrophy (HP:0007210) | 1.75920848 |
| 146 | Cerebral aneurysm (HP:0004944) | 1.75307030 |
| 147 | Atonic seizures (HP:0010819) | 1.74981604 |
| 148 | Apathy (HP:0000741) | 1.73369552 |
| 149 | Cholelithiasis (HP:0001081) | 1.73310415 |
| 150 | Anxiety (HP:0000739) | 1.73041151 |
| 151 | Frequent falls (HP:0002359) | 1.72745359 |
| 152 | Hyperparathyroidism (HP:0000843) | 1.71591358 |
| 153 | Vascular tortuosity (HP:0004948) | 1.70808053 |
| 154 | Broad face (HP:0000283) | 1.70671478 |
| 155 | Peripheral hypomyelination (HP:0007182) | 1.70627168 |
| 156 | Ulnar bowing (HP:0003031) | 1.70149110 |
| 157 | Torticollis (HP:0000473) | 1.69408119 |
| 158 | Wormian bones (HP:0002645) | 1.69083446 |
| 159 | Slow saccadic eye movements (HP:0000514) | 1.68549001 |
| 160 | Mitral stenosis (HP:0001718) | 1.67890176 |
| 161 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.67508971 |
| 162 | Blue sclerae (HP:0000592) | 1.67405382 |
| 163 | Distal lower limb amyotrophy (HP:0008944) | 1.67374449 |
| 164 | Hyperacusis (HP:0010780) | 1.66871174 |
| 165 | Progressive neurologic deterioration (HP:0002344) | 1.66811924 |
| 166 | Shallow orbits (HP:0000586) | 1.66552371 |
| 167 | Diminished motivation (HP:0000745) | 1.65242348 |
| 168 | Stridor (HP:0010307) | 1.63917638 |
| 169 | Disproportionate tall stature (HP:0001519) | 1.63690830 |
| 170 | Arterial tortuosity (HP:0005116) | 1.61750981 |
| 171 | Thin bony cortex (HP:0002753) | 1.61465007 |
| 172 | Recurrent bacterial skin infections (HP:0005406) | 1.61444364 |
| 173 | Joint stiffness (HP:0001387) | 1.61329056 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.11563695 |
| 2 | PKN2 | 3.08612925 |
| 3 | MAP3K12 | 3.02797810 |
| 4 | PRPF4B | 2.97492886 |
| 5 | TTN | 2.68865860 |
| 6 | TESK1 | 2.60670826 |
| 7 | MYLK | 2.59823093 |
| 8 | LMTK2 | 2.55044002 |
| 9 | MAP3K9 | 2.47120213 |
| 10 | KSR2 | 2.41941810 |
| 11 | PHKG1 | 2.11476812 |
| 12 | PHKG2 | 2.11476812 |
| 13 | TESK2 | 2.09099916 |
| 14 | ICK | 1.99596961 |
| 15 | IRAK3 | 1.89977792 |
| 16 | MINK1 | 1.87409632 |
| 17 | SMG1 | 1.85076301 |
| 18 | SIK1 | 1.80267547 |
| 19 | NTRK1 | 1.75788483 |
| 20 | FLT3 | 1.75203372 |
| 21 | TAOK2 | 1.71364625 |
| 22 | MAPKAPK3 | 1.64251379 |
| 23 | ARAF | 1.55809721 |
| 24 | DAPK2 | 1.52054735 |
| 25 | RIPK4 | 1.49740623 |
| 26 | ERN1 | 1.49344283 |
| 27 | GRK5 | 1.48699281 |
| 28 | NTRK3 | 1.45247002 |
| 29 | KIT | 1.42787147 |
| 30 | CAMKK2 | 1.41019785 |
| 31 | SCYL2 | 1.40228775 |
| 32 | RET | 1.39287577 |
| 33 | TAOK1 | 1.37016019 |
| 34 | EPHA2 | 1.36913714 |
| 35 | CAMKK1 | 1.36800386 |
| 36 | MAP3K3 | 1.35610149 |
| 37 | FGFR4 | 1.31436116 |
| 38 | MAP2K3 | 1.30430825 |
| 39 | NEK1 | 1.28913182 |
| 40 | MARK2 | 1.24055309 |
| 41 | MAP3K1 | 1.23402457 |
| 42 | MUSK | 1.22679857 |
| 43 | RIPK1 | 1.22446879 |
| 44 | DAPK3 | 1.21239726 |
| 45 | BCKDK | 1.20736221 |
| 46 | MOS | 1.20519633 |
| 47 | MAP2K4 | 1.20348995 |
| 48 | ILK | 1.16191569 |
| 49 | TIE1 | 1.15110272 |
| 50 | MAP3K11 | 1.13820969 |
| 51 | TYK2 | 1.13187962 |
| 52 | MATK | 1.12758850 |
| 53 | PRKD2 | 1.10395684 |
| 54 | PINK1 | 1.10338779 |
| 55 | PAK4 | 1.08450483 |
| 56 | PAK6 | 1.08385189 |
| 57 | OBSCN | 1.08291608 |
| 58 | IRAK4 | 1.06467081 |
| 59 | CDK19 | 1.06466335 |
| 60 | PIM2 | 1.06448093 |
| 61 | PDK3 | 1.06079211 |
| 62 | PDK4 | 1.06079211 |
| 63 | DAPK1 | 1.04855032 |
| 64 | CAMK1 | 1.03335009 |
| 65 | PTK6 | 0.97462536 |
| 66 | MAP3K2 | 0.97245495 |
| 67 | EEF2K | 0.96575643 |
| 68 | CDC42BPA | 0.96177442 |
| 69 | LRRK2 | 0.95891878 |
| 70 | DMPK | 0.94529895 |
| 71 | LIMK1 | 0.94529160 |
| 72 | RAF1 | 0.93722006 |
| 73 | MAP3K6 | 0.93463750 |
| 74 | PRKD3 | 0.91197489 |
| 75 | PTK2B | 0.90897033 |
| 76 | MAP4K1 | 0.90507354 |
| 77 | STK38 | 0.87433682 |
| 78 | RPS6KA2 | 0.86923672 |
| 79 | EPHA3 | 0.84052582 |
| 80 | PRKG2 | 0.83563552 |
| 81 | CSK | 0.82301394 |
| 82 | IRAK2 | 0.82051429 |
| 83 | TBK1 | 0.81800281 |
| 84 | MAP2K1 | 0.80928202 |
| 85 | MAP2K6 | 0.79188434 |
| 86 | ZAP70 | 0.78109507 |
| 87 | EPHB1 | 0.77259678 |
| 88 | MAP3K7 | 0.77241821 |
| 89 | GRK6 | 0.74917261 |
| 90 | FES | 0.74499544 |
| 91 | TNK2 | 0.74030757 |
| 92 | MAP2K7 | 0.72527791 |
| 93 | DDR2 | 0.70864059 |
| 94 | PRKCH | 0.70823262 |
| 95 | PAK3 | 0.69884613 |
| 96 | HIPK2 | 0.69712365 |
| 97 | MAPK12 | 0.67438796 |
| 98 | BRAF | 0.66053361 |
| 99 | MAP3K4 | 0.65908821 |
| 100 | PIK3CA | 0.65018771 |
| 101 | CDK15 | 0.63156425 |
| 102 | BMX | 0.63128702 |
| 103 | CDK11A | 0.63093449 |
| 104 | KDR | 0.62769974 |
| 105 | TGFBR2 | 0.59214596 |
| 106 | LATS2 | 0.59056842 |
| 107 | PDK1 | 0.58480967 |
| 108 | GRK7 | 0.58472281 |
| 109 | CDK14 | 0.58313983 |
| 110 | CDK5 | 0.58113665 |
| 111 | TGFBR1 | 0.58060891 |
| 112 | CDK18 | 0.57678917 |
| 113 | FER | 0.55645384 |
| 114 | PAK1 | 0.54190469 |
| 115 | JAK2 | 0.53344676 |
| 116 | MST1R | 0.52759661 |
| 117 | CAMK4 | 0.52017819 |
| 118 | TYRO3 | 0.51974400 |
| 119 | PRKD1 | 0.51664853 |
| 120 | TNIK | 0.51563210 |
| 121 | SYK | 0.50271647 |
| 122 | UHMK1 | 0.50212525 |
| 123 | NME2 | 0.49887310 |
| 124 | MAP3K13 | 0.49499649 |
| 125 | MAPKAPK5 | 0.49218180 |
| 126 | PDGFRA | 0.48882279 |
| 127 | MAP3K14 | 0.48800236 |
| 128 | PDPK1 | 0.48696731 |
| 129 | JAK1 | 0.48576579 |
| 130 | SIK3 | 0.48300538 |
| 131 | ROCK2 | 0.48300026 |
| 132 | MAP3K8 | 0.48038815 |
| 133 | ABL2 | 0.47697088 |
| 134 | SIK2 | 0.46569174 |
| 135 | JAK3 | 0.46392788 |
| 136 | MAPK13 | 0.45665039 |
| 137 | KSR1 | 0.45563838 |
| 138 | DYRK1B | 0.45559425 |
| 139 | MAPK11 | 0.45244154 |
| 140 | CAMK2G | 0.45192770 |
| 141 | TEC | 0.45146876 |
| 142 | BLK | 0.44795048 |
| 143 | SGK3 | 0.42995954 |
| 144 | PTK2 | 0.42991319 |
| 145 | MAPK4 | 0.42581534 |
| 146 | ROCK1 | 0.42198197 |
| 147 | MAP3K5 | 0.40615654 |
| 148 | MAPK7 | 0.40524541 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.65940096 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.49575470 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.42137436 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.39800221 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.29904874 |
| 6 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.21440876 |
| 7 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.13927642 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.07341206 |
| 9 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.02533096 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 1.89205143 |
| 11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.89010677 |
| 12 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.88601465 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 1.83926190 |
| 14 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.74854524 |
| 15 | Prion diseases_Homo sapiens_hsa05020 | 1.55887979 |
| 16 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.54068860 |
| 17 | Circadian entrainment_Homo sapiens_hsa04713 | 1.50001672 |
| 18 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.48532952 |
| 19 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.38089214 |
| 20 | Alzheimers disease_Homo sapiens_hsa05010 | 1.36900236 |
| 21 | Long-term potentiation_Homo sapiens_hsa04720 | 1.31325920 |
| 22 | Insulin secretion_Homo sapiens_hsa04911 | 1.30153702 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.28727573 |
| 24 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.25870560 |
| 25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.25523882 |
| 26 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.24932746 |
| 27 | Lysosome_Homo sapiens_hsa04142 | 1.22974758 |
| 28 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.20772490 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.19483465 |
| 30 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.19076336 |
| 31 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.18556223 |
| 32 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.14729047 |
| 33 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.14574536 |
| 34 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.12779733 |
| 35 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 1.12741759 |
| 36 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.12359409 |
| 37 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.12187872 |
| 38 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.12181137 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.12008382 |
| 40 | Glioma_Homo sapiens_hsa05214 | 1.10631566 |
| 41 | Salivary secretion_Homo sapiens_hsa04970 | 1.10234434 |
| 42 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.10064552 |
| 43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.08503330 |
| 44 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.08010241 |
| 45 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.07330778 |
| 46 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.05974946 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.05772680 |
| 48 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.05042305 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03280984 |
| 50 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.02553104 |
| 51 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.02258007 |
| 52 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.01152763 |
| 53 | Thyroid cancer_Homo sapiens_hsa05216 | 1.00075215 |
| 54 | Gap junction_Homo sapiens_hsa04540 | 1.00034999 |
| 55 | Morphine addiction_Homo sapiens_hsa05032 | 0.98206197 |
| 56 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.96667304 |
| 57 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.96393255 |
| 58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.95203850 |
| 59 | Platelet activation_Homo sapiens_hsa04611 | 0.94962439 |
| 60 | Pertussis_Homo sapiens_hsa05133 | 0.94939949 |
| 61 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.94859609 |
| 62 | Renin secretion_Homo sapiens_hsa04924 | 0.94191421 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92792420 |
| 64 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.92208153 |
| 65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.92095228 |
| 66 | Hepatitis C_Homo sapiens_hsa05160 | 0.91717421 |
| 67 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.89716286 |
| 68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.89578632 |
| 69 | GABAergic synapse_Homo sapiens_hsa04727 | 0.88649153 |
| 70 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.87682553 |
| 71 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.86728456 |
| 72 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.86515249 |
| 73 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.85222323 |
| 74 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.84986288 |
| 75 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.83892290 |
| 76 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.83035633 |
| 77 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.82352916 |
| 78 | Huntingtons disease_Homo sapiens_hsa05016 | 0.82228997 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.82056733 |
| 80 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.81965810 |
| 81 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.81651017 |
| 82 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.81138508 |
| 83 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.80236946 |
| 84 | Apoptosis_Homo sapiens_hsa04210 | 0.79601375 |
| 85 | Taste transduction_Homo sapiens_hsa04742 | 0.79411576 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79276586 |
| 87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.78687717 |
| 88 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.78583554 |
| 89 | Galactose metabolism_Homo sapiens_hsa00052 | 0.78022149 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77991789 |
| 91 | Salmonella infection_Homo sapiens_hsa05132 | 0.77843526 |
| 92 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.77329725 |
| 93 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.76615411 |
| 94 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76477498 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.76420400 |
| 96 | Malaria_Homo sapiens_hsa05144 | 0.76041083 |
| 97 | Viral myocarditis_Homo sapiens_hsa05416 | 0.74527383 |
| 98 | Hepatitis B_Homo sapiens_hsa05161 | 0.73929500 |
| 99 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73765218 |
| 100 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71109416 |
| 101 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70647939 |
| 102 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69996090 |
| 103 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.69702044 |
| 104 | Focal adhesion_Homo sapiens_hsa04510 | 0.69329731 |
| 105 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.69288544 |
| 106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.68929610 |
| 107 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.68882807 |
| 108 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.68663381 |
| 109 | Influenza A_Homo sapiens_hsa05164 | 0.67848477 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.67135540 |
| 111 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66744418 |
| 112 | Leishmaniasis_Homo sapiens_hsa05140 | 0.66532128 |
| 113 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.66068203 |
| 114 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65499027 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.64256677 |
| 116 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.63056248 |
| 117 | Amoebiasis_Homo sapiens_hsa05146 | 0.62983331 |
| 118 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61769163 |
| 119 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.60805033 |
| 120 | Shigellosis_Homo sapiens_hsa05131 | 0.60689010 |
| 121 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58651128 |
| 122 | Phagosome_Homo sapiens_hsa04145 | 0.58524542 |
| 123 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57840053 |
| 124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56454335 |
| 125 | Bladder cancer_Homo sapiens_hsa05219 | 0.55998497 |
| 126 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55972029 |
| 127 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55364450 |
| 128 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.54347131 |
| 129 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54088727 |
| 130 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53948692 |
| 131 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53310830 |
| 132 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53090631 |
| 133 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53076416 |
| 134 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.52993684 |
| 135 | Long-term depression_Homo sapiens_hsa04730 | 0.52249837 |
| 136 | Tuberculosis_Homo sapiens_hsa05152 | 0.51707029 |
| 137 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51289497 |
| 138 | Nicotine addiction_Homo sapiens_hsa05033 | 0.51205683 |
| 139 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50986707 |
| 140 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49845750 |
| 141 | Cocaine addiction_Homo sapiens_hsa05030 | 0.49596176 |
| 142 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.48207503 |

